K. Ali

Interim Safety and Immunogenicity of COVID-19 Omicron-BA.1 Variant-Containing Vaccine in Children

R. Bennett, F. Priddy, K. Slobod, 2023, medRxiv.

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

J. Tomassini, J. Nayak, G. Fuchs, 2022, The New England journal of medicine.

Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial

C. Griffin, Honghong Zhou, B. Girard, 2024, The Lancet Infectious Diseases.